• 1
    Crigler JF, Najjar VA. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 1952; 10: 169179.
  • 2
    Chowdhury JR, Wolkoff AW, Arias IM. Hereditary jaundice and disorders of bilirubin metabolism. In: ScriverCR. ed. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1988: 13671408.
  • 3
    Seppen J, Bosnia PJ, Goldhoorn BG, Bakker CTM, Roy Chowdhury J, Roy Chowdhury N, Jansen PLM. et al. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-gluc-uronosyltransferase. J Clin Invest 1994; 94: 23852391.
  • 4
    Schenker S, Hoyumpa AM, McCandless DW. Bilirubin toxicity to the brain (kernicterus) and other tissues. In: OstrowJD. ed. Bile pigments and jaundice—molecular, metabolic and medical aspects. New York: Dekker, 1986: 395419.
  • 5
    Bratlid D. How bilirubin gets into the brain. Clin Perinatol 1990; 17: 449465.
  • 6
    Amit Y, Fedunec S, Panakkezhum DT, Poznansky MJ, Schiff D. Bilirubinneural cell interaction: characterization of initial cell surface binding leading to toxicity in the neuroblastoma cell line N-115. Biochim Biophys Acta 1990; 1055: 3642.
  • 7
    McDonagh AF, Lightner DA. Phototherapy and the photobiology of bilirubin. Semin Liver Dis 1988; 8: 272283.
  • 8
    Ennever JF, Costarino AT, Polin RA, Speck WT. Rapid clearance of a structural isomer of bilirubin during phototherapy. J Clin Invest 1987; 79: 16741678.
  • 9
    Davis DR, Yeary RA, Lee K. The failure of phototherapy to reduce plasma bilirubin levels in the bile duct-ligated rat. J Pediatr 1981; 99: 956958.
  • 10
    Bloomer JR, Sharp HL. The liver in Crigler-Najjar syndrome, protoporphyria, and other metabolic disorders. Hepatology 1984; 4: 18S21S.
  • 11
    Reichen J. Familial unconjugated hyperbilirubinemia syndromes. Semin Liver Dis 1983; 3: 2435.
  • 12
    Kaufman SS, Wood RP, Shaw BW Jr, Markin RS, Rosenthal P, Gridelli B, Vanderhoof JA. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 1986; 6: 12591262.
  • 13
    Shevell MI, Bernard B, Adelson JW, Doody DP, Laberge JM, Guttman FM. Crigler-Najjar syndrome type I. treatment by home phototherapy followed by orthotopic hepatic transplantation. J Pediatr 1987; 110: 429431.
  • 14
    Schmid R, Hammaker L. Metabolism and disposition of 14C-bilirubin in congenital nonhemolytic jaundice. J Clin Invest 1963; 42: 17201734.
  • 15
    Kapitulnik J, Ostrow JD. Stimulation of bilirubin catabolism in jaundiced Gunn rats by an inducer of microsomal mixed-function monooxygenases. Proc Natl Acad Sci U S A 1977; 75: 682685.
  • 16
    Kotal P, Fevery J. Direct permeation of unconjugated bilirubin (UCB) through the intestinal wall and conversion to urobilinogen I (ugen) is a major elimination route in homozygous Gunn rats. Hepatology 1989; 10: 593.
  • 17
    Lester R, Schmid R. Intestinal absorption of bile pigments I. The enterohepatic circulation of bilirubin in the rat. J Clin Invest 1963; 42: 736746.
  • 18
    Brodersen R. Intestinal reabsorption of unconjugated bilirubin: a possible contributing factor in neonatal jaundice. Lancet 1963; 1: 1242.
  • 19
    Gilbertsen AS, Bossenmaier I, Cardinal R. Enterohepatic circulation of unconjugated bilirubin in man. Nature 1962; 196: 141142.
  • 20
    Lester R, Schmid R. Intestinal absorption of bile pigments II. Bilirubin absorption in man. New Engl J Med 1963; 269: 178182.
  • 21
    Poland RL, Odell GB. Physiologic jaundice: the enterohepatic circulation of bilirubin. New Engl J Med 1971; 284: 16.
  • 22
    Davis DR, Yeary RA, Lee K. Activated charcoal decreases plasma bilirubin levels in the hyperbilirubinemic rat. Pediatr Res 1983; 17: 208209.
  • 23
    Davis DR, Yeary RA. Activated charcoal as an adjunct to phototherapy for neonatal jaundice. Dev Pharmacol Ther 1987; 10: 1220.
  • 24
    Ulstrom RA, Eisenklam E. The enterohepatic shunting of bilirubin in the newborn infant. I. Use of oral-activated charcoal to reduce normal serum bilirubin values. J Pediatr 1964; 65: 2737.
  • 25
    Lester R, Hammaker L, Schmid R. A new therapeutic approach to unconjugated hyperbilirubinemia. Lancet 1962; Dec 15: 1257.
  • 26
    Odell GB, Gutcher GR, Whitington PF, Yang G. Enteral administration of agar as an effective adjunct to phototherapy of neonatal hyperbilirubinemia. Pediatr Res 1983; 17: 810814.
  • 27
    Poland RL, Avery GB, Goetcherian E, Odell GB. Treatment of Crigler-Najjar syndrome with agar. Pediatr Res 1972; 6: 377.
  • 28
    Caglayan S, Candemir H, Aksit S, Kansoy S, Asik S, Yaprak I. Superiority of oral agar and phototherapy combination in the treatment of neonatal hyperbilirubinemia. Pediatrics 1993; 92: 8689.
  • 29
    Kemper K, Horwitz RI, McCarthy P. Decreased neonatal serum bilirubin with plain agar: a meta-analysis. Pediatrics 1988; 82: 631638.
  • 30
    Ostrow JD, Hammaker L, Schmid R. The preparation of crystalline bilirubin-C14. J Clin Invest 1961; 40: 14421452.
  • 31
    McDonagh AF, Palma LA, Lauff JJ, Wu TU. Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. J Clin Invest 1984; 74: 763770.
  • 32
    Bieri JG, Stoewsand GS, Briggs GM, Phillips RW, Woodard JC, Knapka JJ. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutr 1977; 107: 13401348.
  • 33
    Bieri JG. Second report of the ad hoc committee on standards for nutritional studies. J Nutr 1980; 110: 1726.
  • 34
    Vonk RJ, Van Doom ABD, Strubbe JH. Bile secretion and bile composition in the freely moving, unanaesthetized rat with a permanent biliary drainage: influence of food intake on bile flow. Clin Sci Mol Med 1978; 55: 253259.
  • 35
    Van der Veere CN, Schoemaker B, Van der Meer R, Groen AK, Jansen PLM, Ou de Elferink RPJ. Rapid association of unconjugated bilirubin with amorphous calcium phosphate. J Lipid Res 1995; 36: 16971707.
  • 36
    Carey MC. Pathogenesis of gallstones. Am J Surg 1993; 165: 410419.
  • 37
    Van der Meer R, De Vries HT. Differential binding of glycine- and taurineconjugated bile acids to insoluble calcium phosphate. Biochem J 1985; 229: 265268.
  • 38
    Van der Meer R. Covers MJAP. Dietary phosphate does not inhibit the protective effects of calcium on luminal solubility and cytotoxicity of bile acids and fatty acids. Gastroenterology 1991; 100: A407.
  • 39
    Lapré JA, De Vries HT, Termont DSML, Kleibeuker JH, DeVries EGE, Van der Veere R. Mechanism of the protective effect of supplemental dietary calcium on cytolytic activity of fecal water. Cancer Res 1993; 53: 248253.
  • 40
    Van der Meer R, Welberg JWM, Kuipers F, Kleibeuker JH, Mulder NH, Termont DSML, Vonk RJ. et al. Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile acids. Gastroenterology 1990; 99: 16531659.
  • 41
    Kuipers F, Havinga R, Bosschieter H, Toorop GP, Hindriks FR, Vonk RJ. Enterohepatic circulation in the rat. Gastroenterology 1985; 88: 403411.
  • 42
    Odell GB, Bolen JL, Poland RL, Seungdamrong S, Cukier JO. Protection from bilirubin nephropathy in jaundiced Gunn rats. Gastroenterology 1974; 66: 12181224.
  • 43
    Rungby J, Kassem M, Eriksen EF, Danscher G. The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background. Histochem J 1993; 25: 446451.
  • 44
    Wiese G, Ballowitz L, Korbmacher C. Pharmacokinetic studies of the enterohepatic circulation in Gunn rats. Klin Paediatr 1985; 197: 366370.
  • 45
    Anderson ICE, Kappas A. Dietary regulation of cytochrome P450. Annu Rev Nutr 1991; 11: 141167.
  • 46
    Blanckaert N, Fevery J, Heirwegh KPM, Compernolle F. Characterization of the major diazo-positive pigments in bile of homozygous Gunn rats. Biochem J 1977; 164: 237249.
  • 47
    Haynes RC. Agents affecting calcification: calcium, parathyroid hormone, calcitonin, vitamin D. and other compounds. In: Goodman GilmanA. RailTW. NiesAS. TaylorP. eds. The pharmacological basis of therapeutics. New York: Pergamon, 1988: 14961504.